Since P-gp overexpression appeared to confer resistance to some FINs, we validated the results in parental OVCAR8 ovarian cancer cells and P-gp-overexpressing NCI/ADR-RES cells that were derived from OVCAR8 cells by selection with doxorubicin. Here, PGP is linked to ovarian cancer.